Category: Blood Diseases
Global Blood Diseases
-
The 2025-2030 World Outlook for Von Willebrand Disease Treatments
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Rare Hemophilia Factors
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Oral Iron Therapy for Iron Deficiency Anemia
... estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. ... Read More
-
The 2025-2030 World Outlook for Plasma Fractionation
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Sickle Cell Anemia Treatments
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Hemophilia Treatments
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Iron Deficiency Anemia Therapies
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Rare Hematology Plasma-Derived Factors
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Haemoglobinopathies
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2025-2030 World Outlook for Hemoglobinopathies
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2025-2030 World Outlook for Monocyte Activation Test Kits
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Blood Cancers
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Bleeding Disorders Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Sickle Cell Disease Treatments
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Sickle Cell Disease Hemoglobinopathies
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Plasma Fractionation of Intravenous Immunoglobulins
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
Global Anemia Therapeutics Market Growth (Status and Outlook) 2024-2030
... market, the Anemia Therapeutics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Anemia Therapeutics ... Read More
-
Global Alpha Thalassemia Market Growth (Status and Outlook) 2024-2030
... market, the Alpha Thalassemia is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Alpha Thalassemia ... Read More
-
Global Acquired Aplastic Anemia Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Acquired Aplastic Anemia is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Hemophilia A (Factor VIII Deficiency) - Global Clinical Trials Review, 2024
... Deficiency) Clinical trials scenario. This report provides top line data relating to the clinical trials on Hemophilia A (Factor VIII Deficiency). Report includes an overview of trial numbers and their average enrollment in top countries ... Read More
-
Global Rare Hemophilia Factors Market Growth (Status and Outlook) 2024-2030
... demand in downstream market, the Rare Hemophilia Factors is forecast to a readjusted size of US$ 242.3 million by 2030 with a CAGR of 3.0% during review period. The research report highlights the growth potential ... Read More
-
Global Thalassemia Market Growth (Status and Outlook) 2024-2030
... the Thalassemia is forecast to a readjusted size of US$ 5324.4 million by 2030 with a CAGR of 8.8% during review period. The research report highlights the growth potential of the global Thalassemia market. Thalassemia ... Read More
-
Global Renal Anemia Therapeutics Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Renal Anemia Therapeutics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Chemotherapy-Induced Anemia Global Market Report 2024
... Surgical Centers; Multispecialty Clinics; Cancer Research Centers; Cancer Rehabilitation CentersCovering: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Novartis AG Chemotherapy-Induced Anemia Global Market Report 2024 from The Business Research ... Read More
-
Thalassemia Drugs Global Market Report 2024
... Inc.; Merck & Co. Inc.; Novartis AG; Sanofi S.A.; Fresenius Kabi AG Thalassemia Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need ... Read More
Research Assistance
